Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948061 · ClinicalTrials.gov registry record · NA
Cardiometabolic Effects of Sweet Cherry Juice
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03948061: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.
NCT03948061 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03948061, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study aims to determine the effects of consuming sweet cherry juice on cardiovascular function, glucose regulation, and lipid status in overweight human subjects. The investigators hypothesize that sweet cherry juice consumption will improve metabolic and physiological status in overweight persons compared to a placebo.
Primary Outcome
Blood pressure measured using a Continuous Non-invasive Arterial Pressure (CNAP®) device in mmHg
Interventions
- OTHER Placebo beverage
- OTHER Cherry juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-10-25 |
| Phase | NA |
What the finished NCT03948061 record still lists
NCT03948061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo beverage is the first listed.
NCT03948061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03948061 about?
NCT03948061 is a clinical study titled "Cardiometabolic Effects of Sweet Cherry Juice". This study aims to determine the effects of consuming sweet cherry juice on cardiovascular function, glucose regulation, and lipid status in overweight human subjects. The investigators hypothesize that sweet cherry juice consumption will improve metabolic and physiological status in overweight pers...
What is the current status of trial NCT03948061?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-10-01. Estimated completion is 2023-10-25.
What interventions are being tested in trial NCT03948061?
The interventions under investigation include: Placebo beverage (OTHER), Cherry juice (OTHER).
Who is sponsoring clinical trial NCT03948061?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03948061's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI